Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL365987 | 0.87 | GAA (0.34) | GAAMAPT | |
| SCHEMBL3118101 | 0.76 | GAA (0.39) | GAAMAPT | |
| SCHEMBL11993899 | 0.72 | GAA (0.35) | GAAMAPT | |
| SCHEMBL367620 | 0.65 | GAA (0.34) | GAAMAPT | |
| SCHEMBL4445110 | 0.65 | GAA (0.34) | GAAMAPT | |
| SCHEMBL5734597 | 0.65 | — | — | |
| SCHEMBL18562457 | 0.64 | GAA (0.44) | GAAMAPT | |
| SCHEMBL4540870 | 0.64 | GAA (0.44) | GAAMAPT | |
| SCHEMBL6056252 | 0.64 | GAA (0.44) | GAAMAPT | |
| SCHEMBL12159337 | 0.64 | GAA (0.44) | GAAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4392168-A1 | IONIC LIQUID-BASED COMPOSITE MEMBRANES USING FUNCTIONAL CROSS-LINKERS | The Regents of the University of Colorado, a body corporate (US) | 2024-07-03 | — | — | EP | disclosed |
| WO-2024081715-A2 | LIPID NANOPARTICLE (LNP) COMPOSITIONS FOR PLACENTA-SELECTIVE CARGO DELIVERY, AND METHODS OF USE THEREOF | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2024-04-18 | — | — | WO | disclosed |
| WO-2023028323-A9 | IONIC LIQUID-BASED COMPOSITE MEMBRANES USING FUNCTIONAL CROSS-LINKERS | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) | 2024-04-04 | — | — | WO | disclosed |
| WO-2022178428-A9 | TARGETED BIFUNCTIONAL DEGRADERS AND METHODS USING SAME | YALE UNIVERSITY (US) | 2023-08-17 | — | — | WO | disclosed |
| EP-4216949-A1 | SELECTIVE AGONISTS OF 5-HT2A RECEPTOR AND METHODS OF USE | Yale University (US) | 2023-08-02 | — | — | EP | disclosed |
| EP-4168499-A1 | METHODS OF POLYMERIZATION WITH AROMATIC THIOL INITIATORS | The Regents of the University of Colorado, a body corporate (US) | 2023-04-26 | — | — | EP | disclosed |
| WO-2023056282-A1 | COMPOSITIONS AND METHODS FOR T CELL TARGETED DELIVERY OF THERAPEUTIC AGENTS | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2023-04-06 | — | — | WO | disclosed |
| WO-2023028323-A1 | IONIC LIQUID-BASED COMPOSITE MEMBRANES USING FUNCTIONAL CROSS-LINKERS | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) | 2023-03-02 | — | — | WO | disclosed |
| EP-4107197-A2 | NETWORK TOUGHENING OF ADDITIVELY MANUFACTURED, HIGH GLASS TRANSITION TEMPERATURE MATERIALS VIA SEQUENTIALLY CURED, INTERPENETRATING POLYMERS | Rowan University (US) | 2022-12-28 | — | — | EP | disclosed |
| WO-2022150584-A1 | NON-COVALENT INHIBITORS OF THE MAIN PROTEASE OF SARS-COV-2 AND METHODS OF USE | YALE UNIVERSITY (US) | 2022-07-14 | — | — | WO | disclosed |
| WO-2008150446-A1 | INHIBITORS OF PROTEIN KINASES | LIANG CONGXIN (US) | 2008-12-11 | — | — | WO | disclosed |
| WO-2008115369-A2 | INHIBITORS OF FOCAL ADHESION KINASE | THE SCRIPPS RESEARCH INSTITUTE (US) | 2008-09-25 | — | — | WO | disclosed |
| WO-2008107362-A2 | STABILISER AND INHIBITORS OF FACTOR VII | NOVO NORDISK HEALTH CARE AG (DK) | 2008-09-12 | — | — | WO | disclosed |
| WO-2008107363-A1 | NEW BLOOD COAGULATION FACTOR INHIBITORS | NOVO NORDISK HEALTH CARE AG (DK) | 2008-09-12 | — | — | WO | disclosed |
| WO-2008086161-A1 | MACROCYCLIC HEPATITIS C PROTEASE INHIBITORS | PHENOMIX CORPORATION (US) | 2008-07-17 | — | — | WO | disclosed |
| WO-2008070358-A2 | N-CYCLOPROPYL-HYDROXYPROLINE-BASED TRIPEPTIDIC HEPATITIS C SERINE PROTEASE INHIBITORS CONTAINING AN ISOINDOLE, PYRROLOPYRIDINE, PYRROLOPYRIMIDINE OR PYRROLOPYRAZINE HETEROCYCLE IN THE SIDE CHAIN | PHENOMIX CORPORATION (US) | 2008-06-12 | — | — | WO | disclosed |
| WO-2007089618-A2 | HEPATITIS C SERINE PROTEASE INHIBITORS AND USES THEREFOR | PHENOMIX CORPORATION (US) | 2007-08-09 | — | — | WO | disclosed |
| EP-1689757-A4 | HETEROCYCLIC BORONIC ACID COMPOUNDS | PHENOMIX CORP (US) | 2007-01-10 | — | — | EP | disclosed |
| EP-1689757-A1 | HETEROCYCLIC BORONIC ACID COMPOUNDS | Phenomix Corporation (US) | 2006-08-16 | — | — | EP | disclosed |
| WO-2005047297-A1 | HETEROCYCLIC BORONIC ACID COMPOUNDS | PHENOMIX CORPORATION (US) | 2005-05-26 | — | — | WO | disclosed |